-
IRSJD collaborates in the new biomedical proteomics unit led by IRB Barcelona
The Institute of Research in Biomedicine, together with the Institut de Recerca Sant Joan de Déu, Josep Carreras Leukemia Research Institute, Vall d'Hebron Institute of Oncology and the University of Barcelona, receives ERDF support to acquire cutting-edge technology in the field of proteomics.
-
Researchers find new transposon-derived genes related to autism and other neurological diseases
Institut de Recerca Sant Joan de Déu researchers collaborate in this study led by Professor Jordi Garcia Fernàndez, from the Faculty of Biology and the Institute of Biomedicine of the University of Barcelona (IBUB).
-
Gene crucial for growth of Ewing sarcoma uncovered
Researchers at the Institut de Recerca Sant Joan de Déu in collaboration with those at Centre for Genomic Regulation have discovered that RING1B is a critical gene for the development of Ewing sarcoma, a rare type of developmental cancer that presents in bones and soft tissues.
-
Researchers discover a new genetic disease of the nervous and cardiac systems
The study, led by Dra. Àngels Garcia-Cazorla (Institut de Recerca Sant Joan de Déu), and scientists from IRSJD, IDIBELL and CIBERER, is published in the prestigious journal 'Acta Neuropathologica'.
-
Institut de Recerca Sant Joan de Déu and ICFO create a joint lab to improve neonatal and paediatric health care
The new joint laboratory will advance the use and development of photonic technologies to understand, diagnose, monitor and treat paediatric diseases.
-
Dr Maria Rubio awarded a scientific excellence grant from the European Research Council (ERC)
This financial award will fund an intervention in several primary care centres in Catalonia and is designed to encourage people with diabetes and cardiovascular disease to begin and comply with the pharmacological treatments as prescribed by their physician.
-
Reproduce various stages of Ewing's sarcoma in mice
Researchers at Institut de Recerca Sant Joan de Déu reproduce various stages of Ewing's sarcoma in mice to explain its resistance to medication.
-
The european ImmunAID project starts its clinical phase
The ImmunAID project aims to develop new diagnostic signatures for systemic auto-inflammatory diseases (SAID). Ultimately, the aim is to offer better care for these rare disease patients. Systemic auto-inflammatory diseases (SAID) are a complex and poorly understood group of rare diseases.
-
Gate2Brain, the “key” to transporting drugs into the brain and improving their effectiveness
Gate2Brain technology is based on a research line developed at IRB Barcelona and breakthroughs made jointly with the University of Barcelona and the Institut de Recerca Sant Joan de Déu - SJD Barcelona Children’s Hospital.
